mRNA Vaccines & Therapeutics 2017 Global Market Analysis, Company Profiles And Industrial Overview Research Report Forecasting To 2022

mRNA Vaccines & Therapeutics Market 2017 

Wiseguyreports.Com Adds “mRNA Vaccines & Therapeutics Market -Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2022” To Its Research Database.

Description:    

This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in mRNA Vaccines & Therapeutics industry.

This report splits mRNA Vaccines & Therapeutics market By Cancer Vaccines, By Infectious Disease Vaccines, By In vivo Therapeutics, By Gene Editing, which covers the history data information from 2012 to 2016 and forecast from 2017 to 2022.

This report focuses Global market, it covers details as following:

Major Companies:
Argos Therapeutics (U.S.)
AstraZeneca (UK)
Bayer AG (Germany)
BioNTech (Germany)
Boehringer Ingelheim (Germany)
CRISPR Therapeutics (Switzerland)
CureVac (Germany)
ETheRNA immunotherapies (Belgium)
Ethris (Germany)
GlaxoSmithKline Vaccines (UK)
In-Cell-Art (France)
Intellia Therapeutics (U.S.)
Janssen (Belhium)
Kernal Biologics (U.S.)
MaxCyte (U.S.)
Moderna Therapeutics (U.S.)
Novartis (U.S.)
PhaseRx (U.S.)
Precision NanoSystems (Canada)
RaNa Therapeutics (U.S.)

Request for Sample Report@ https://www.wiseguyreports.com/sample-request/1703446-global-mrna-vaccines-therapeutics-detailed-analysis-report-2017-2022
Main Regions:
North America
United States
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others

Main Product Type:
mRNA Vaccines & Therapeutics Market, by Cancer Vaccines
Standardized preselected
Individualized shared antigens
Individualized neoantigens
mRNA Vaccines & Therapeutics Market, by Infectious Disease Vaccines
Prophylactic vaccines
Therapeutic vaccines
Synthetic self-amplifying mRNA vaccines for pandemic outbreaks
mRNA Vaccines & Therapeutics Market, by In vivo Therapeutics
Therapeutic proteins
Therapeutic antibodies
mRNA Vaccines & Therapeutics Market, by Gene Editing
Ex vivo gene editing of gene defects
In vivo gene editing of gene defects
Ex vivo gene editing of autologous and allogeneic T-cells

Main Applications:
Hospital
Clinic
Others

Enquiry before Buying @ https://www.wiseguyreports.com/enquiry/1703446-global-mrna-vaccines-therapeutics-detailed-analysis-report-2017-2022

Table of Contents:

Global mRNA Vaccines & Therapeutics Detailed Analysis Report 2017-2022
Chapter One mRNA Vaccines & Therapeutics Market Overview
1.1 Global mRNA Vaccines & Therapeutics Market Sales Volume Revenue and Price 2012-2022
1.2 mRNA Vaccines & Therapeutics, By Cancer Vaccines 2012-2022
1.2.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Cancer Vaccines 2012-2022
1.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Cancer Vaccines 2012-2022
1.2.3 Global mRNA Vaccines & Therapeutics Price by Cancer Vaccines 2012-2022
1.2.4 Standardized preselected
1.2.5 Individualized shared antigens
1.2.6 Individualized neoantigens
1.3 mRNA Vaccines & Therapeutics, by Infectious Disease Vaccines 2012-2022
1.3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Infectious Disease Vaccines 2012-2022
1.3.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Infectious Disease Vaccines 2012-2022
1.3.3 Global mRNA Vaccines & Therapeutics Price by Infectious Disease Vaccines 2012-2022
1.3.4 Prophylactic vaccines
1.3.5 Therapeutic vaccines
1.3.6 Synthetic self-amplifying mRNA vaccines for pandemic outbreaks
1.4 mRNA Vaccines & Therapeutics, by In vivo Therapeutics 2012-2022
1.4.1 Global mRNA Vaccines & Therapeutics Sales Market Share by In vivo Therapeutics 2012-2022
1.4.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by In vivo Therapeutics 2012-2022
1.4.3 Global mRNA Vaccines & Therapeutics Price by In vivo Therapeutics 2012-2022
1.4.4 Therapeutic proteins
1.4.5 Therapeutic antibodies
1.5 mRNA Vaccines & Therapeutics, by Gene Editing 2012-2022
1.5.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Gene Editing 2012-2022
1.5.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Gene Editing 2012-2022
1.5.3 Global mRNA Vaccines & Therapeutics Price by Gene Editing 2012-2022
1.5.4 Ex vivo gene editing of gene defects
1.5.5 In vivo gene editing of gene defects
1.5.6 Ex vivo gene editing of autologous and allogeneic T-cells

Chapter Three mRNA Vaccines & Therapeutics by Players 2012-2017
3.1 Global mRNA Vaccines & Therapeutics Sales Volume Market Share by Players 2012-2017
3.2 Global mRNA Vaccines & Therapeutics Revenue Share by Players 2012-2017
3.3 Global Top Players mRNA Vaccines & Therapeutics Key Product Model and Market Performance
3.4 Global Top Players mRNA Vaccines & Therapeutics Key Target Consumers and Market Performance

……

Chapter Five Global Top Players Profile
5.1 Argos Therapeutics (U.S.)
5.1.1 Argos Therapeutics (U.S.) Company Details and Competitors
5.1.2 Argos Therapeutics (U.S.) Key mRNA Vaccines & Therapeutics Models and Performance
5.1.3 Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
5.1.4 Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
5.2 AstraZeneca (UK)
5.2.1 AstraZeneca (UK) Company Details and Competitors
5.2.2 AstraZeneca (UK) Key mRNA Vaccines & Therapeutics Models and Performance
5.2.3 AstraZeneca (UK) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
5.2.4 AstraZeneca (UK) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
5.3 Bayer AG (Germany)
5.3.1 Bayer AG (Germany) Company Details and Competitors
5.3.2 Bayer AG (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
5.3.3 Bayer AG (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
5.3.4 Bayer AG (Germany) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
5.4 BioNTech (Germany)
5.4.1 BioNTech (Germany) Company Details and Competitors
5.4.2 BioNTech (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
5.4.3 BioNTech (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
5.4.4 BioNTech (Germany) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
5.5 Boehringer Ingelheim (Germany)
5.5.1 Boehringer Ingelheim (Germany) Company Details and Competitors
5.5.2 Boehringer Ingelheim (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
5.5.3 Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
5.5.4 Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
5.6 CRISPR Therapeutics (Switzerland)
5.6.1 CRISPR Therapeutics (Switzerland) Company Details and Competitors
5.6.2 CRISPR Therapeutics (Switzerland) Key mRNA Vaccines & Therapeutics Models and Performance
5.6.3 CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
5.6.4 CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
5.7 CureVac (Germany)
5.7.1 CureVac (Germany) Company Details and Competitors
5.7.2 CureVac (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
5.7.3 CureVac (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
5.7.4 CureVac (Germany) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
5.8 ETheRNA immunotherapies (Belgium)
5.8.1 ETheRNA immunotherapies (Belgium) Company Details and Competitors
5.8.2 ETheRNA immunotherapies (Belgium) Key mRNA Vaccines & Therapeutics Models and Performance
5.8.3 ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
5.8.4 ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
5.9 Ethris (Germany)
5.9.1 Ethris (Germany) Company Details and Competitors
5.9.2 Ethris (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
5.9.3 Ethris (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
5.9.4 Ethris (Germany) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
5.10 GlaxoSmithKline Vaccines (UK)
5.10.1 GlaxoSmithKline Vaccines (UK) Company Details and Competitors
5.10.2 GlaxoSmithKline Vaccines (UK) Key mRNA Vaccines & Therapeutics Models and Performance
5.10.3 GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
5.10.4 GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
5.11 In-Cell-Art (France)
5.12 Intellia Therapeutics (U.S.)
5.13 Janssen (Belhium)
5.14 Kernal Biologics (U.S.)
5.15 MaxCyte (U.S.)
5.16 Moderna Therapeutics (U.S.)
5.17 Novartis (U.S.)
5.18 PhaseRx (U.S.)
5.19 Precision NanoSystems (Canada)
5.20 RaNa Therapeutics (U.S.)

Continued…..

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1703446

For accessing accurate and deep understanding and to gain latest insights and key developments in the area of your interest, we also have a list of conferences in which you will be interested in, for more information, cordially check:

https://www.wiseguyreports.com/conferences

For updating knowledge or for thoroughly understanding various terminologies, we also have vast list of seminars for your reference, for more information cordially check:

https://www.wiseguyreports.com/seminars

 

Contact US:                        

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s